Raúl Rincón

2.5k total citations · 1 hit paper
37 papers, 1.9k citations indexed

About

Raúl Rincón is a scholar working on Atomic and Molecular Physics, and Optics, Molecular Biology and Oncology. According to data from OpenAlex, Raúl Rincón has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Atomic and Molecular Physics, and Optics, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Raúl Rincón's work include Surface and Thin Film Phenomena (12 papers), Semiconductor materials and interfaces (9 papers) and Semiconductor Quantum Structures and Devices (7 papers). Raúl Rincón is often cited by papers focused on Surface and Thin Film Phenomena (12 papers), Semiconductor materials and interfaces (9 papers) and Semiconductor Quantum Structures and Devices (7 papers). Raúl Rincón collaborates with scholars based in Spain, Chile and United Kingdom. Raúl Rincón's co-authors include F. Flóres, R. Saiz-Pardo, Jesús García‐Foncillas, Ion Cristóbal, Federico Rojo, Juan Madoz‐Gúrpide, Rebeca Manso, Sandra Zazo, Cristina Caramés and F. J. Garcı́a-Vidal and has published in prestigious journals such as Journal of Clinical Oncology, Physical review. B, Condensed matter and Scientific Reports.

In The Last Decade

Raúl Rincón

37 papers receiving 1.9k citations

Hit Papers

Interfaces in crystalline materials 1994 2026 2004 2015 1994 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interfaces in crystalline materials
    1994 1.4k citations F. Flóres, R. Saiz-Pardo et al. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raúl Rincón Spain 13 1.1k 564 365 331 278 37 1.9k
Tatsuya Okada Japan 24 688 0.6× 414 0.7× 244 0.7× 317 1.0× 278 1.0× 202 2.3k
Peter Lin Canada 22 1.0k 0.9× 1.1k 1.9× 300 0.8× 88 0.3× 416 1.5× 46 2.2k
Toshiyuki Fujii Japan 27 1.2k 1.1× 1.1k 2.0× 77 0.2× 292 0.9× 422 1.5× 161 2.3k
Junling Chen China 26 1.6k 1.5× 758 1.3× 224 0.6× 88 0.3× 411 1.5× 168 2.4k
Dongping Liu China 27 1.4k 1.3× 289 0.5× 174 0.5× 322 1.0× 485 1.7× 153 2.3k
Francisco Eiichi Fujita Japan 27 1.6k 1.4× 1.1k 1.9× 99 0.3× 294 0.9× 237 0.9× 170 2.5k
Shin Nishio Japan 22 553 0.5× 132 0.2× 320 0.9× 251 0.8× 61 0.2× 143 2.4k
Hiroyuki Okamoto Japan 19 427 0.4× 353 0.6× 82 0.2× 138 0.4× 63 0.2× 175 2.0k
J. A. King United States 21 309 0.3× 486 0.9× 123 0.3× 224 0.7× 266 1.0× 51 1.7k
Isao Matsui Japan 23 814 0.7× 446 0.8× 88 0.2× 247 0.7× 143 0.5× 88 1.6k

Countries citing papers authored by Raúl Rincón

Since Specialization
Citations

This map shows the geographic impact of Raúl Rincón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl Rincón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl Rincón more than expected).

Fields of papers citing papers by Raúl Rincón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl Rincón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl Rincón. The network helps show where Raúl Rincón may publish in the future.

Co-authorship network of co-authors of Raúl Rincón

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl Rincón. A scholar is included among the top collaborators of Raúl Rincón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl Rincón. Raúl Rincón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Clive R., Carlos H. Barrios, Manuel Ruíz-Borrego, et al.. (2024). Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial.. Journal of Clinical Oncology. 42(16_suppl). 516–516. 1 indexed citations
2.
Soldevilla, Beatriz, Ángeles López‐Gonzálvez, Anna La Salvia, et al.. (2021). Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance. Cancers. 13(11). 2634–2634. 16 indexed citations
3.
Martínez‐Useros, Javier, Weiyao Li, María Jesús Fernández‐Aceñero, et al.. (2019). UNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition. Journal of Clinical Medicine. 8(4). 560–560. 25 indexed citations
4.
Baldán‐Martín, Montserrat, Juan Antonio López, Elena Rodríguez‐Sánchez, et al.. (2018). Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals. Scientific Reports. 8(1). 4802–4802. 7 indexed citations
5.
Rincón, Raúl, Sandra Zazo, Cristina Chamizo, et al.. (2016). c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2780–2790. 12 indexed citations
6.
Cristóbal, Ion, Cristina Caramés, Raúl Rincón, et al.. (2016). Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer. Oncotarget. 8(25). 40169–40180. 16 indexed citations
7.
Cristóbal, Ion, Raúl Rincón, Rebeca Manso, et al.. (2014). Deregulation of the PP2A Inhibitor SET Shows Promising Therapeutic Implications and Determines Poor Clinical Outcome in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 21(2). 347–356. 61 indexed citations
8.
Cristóbal, Ion, Rebeca Manso, Raúl Rincón, et al.. (2014). PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential. Molecular Cancer Therapeutics. 13(4). 938–947. 104 indexed citations
9.
Puerto‐Nevado, Laura del, Federico Rojo, Sandra Zazo, et al.. (2014). Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy. British Journal of Cancer. 110(11). 2700–2707. 21 indexed citations
10.
Cristóbal, Ion, Rebeca Manso, Raúl Rincón, et al.. (2014). Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer. British Journal of Cancer. 111(4). 756–762. 17 indexed citations
11.
Cristóbal, Ion, Raúl Rincón, Rebeca Manso, et al.. (2014). Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1823–1829. 32 indexed citations
12.
Izarzugaza, Yann, Manuel Dómine, Federico Rojo, et al.. (2012). Prevalence of EGFR mutations in non-small cell lung cancer (NSCLC) smoker patients.. Journal of Clinical Oncology. 30(15_suppl). e21015–e21015. 1 indexed citations
13.
Dómine, Manuel, Yann Izarzugaza, Federico Rojo, et al.. (2012). KRAS mutations as predictive biomarker in patients with EGFR wild-type stage IV nonsquamous non-small cell lung cancer (NSCLC) recruited in a phase II clinical study with carboplatin-docetaxel-bevacizumab.. Journal of Clinical Oncology. 30(15_suppl). e18069–e18069. 1 indexed citations
14.
Zazo, Sandra, Juan Madoz‐Gúrpide, Manuel Dómine, et al.. (2012). Role of c-MET pathway in the outcome prediction of cetuximab-based therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 30(15_suppl). 5520–5520. 2 indexed citations
15.
Yeyati, A. Levy, A. Martı́n-Rodero, F. Flóres, José Ortega, & Raúl Rincón. (1996). Metal-insulator transition for K on GaAs(100)-As rich surfaces. Applied Surface Science. 104-105. 248–252. 5 indexed citations
16.
Rincón, Raúl, José Ortega, F. Flóres, A. Levy Yeyati, & A. Martı́n-Rodero. (1995). Quasi-one-dimensional structures and metallization for the deposition of K on GaAs(100) As-rich surfaces. Physical review. B, Condensed matter. 52(23). 16345–16348. 7 indexed citations
17.
Flóres, F., R. Saiz-Pardo, & Raúl Rincón. (1994). Interfaces in crystalline materials. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2364. 388–388. 1379 indexed citations breakdown →
18.
Flóres, F., Rúben Pérez, Raúl Rincón, & R. Saiz-Pardo. (1993). Electron states at semiconductor interfaces: the intrinsic and extrinsic charge neutrality levels. Philosophical Transactions of the Royal Society of London Series A Physical and Engineering Sciences. 344(1673). 567–577. 5 indexed citations
19.
Flóres, F., R. Saiz-Pardo, Raúl Rincón, et al.. (1993). The interaction of atoms with semiconductor surfaces: the case of Sb on GaAs(110). Journal of Physics Condensed Matter. 5(33A). A41–A50. 4 indexed citations
20.
Ortega, José, Raúl Rincón, Rúben Pérez, F. J. Garcı́a-Vidal, & F. Flóres. (1992). Schottky barrier formation: Al deposition on GaAs(110). Applied Surface Science. 60-61. 736–741. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuya Okada Breakdown of academic impact, for papers by Peter Lin Breakdown of academic impact, for papers by Toshiyuki Fujii Breakdown of academic impact, for papers by Junling Chen Breakdown of academic impact, for papers by Dongping Liu Breakdown of academic impact, for papers by Francisco Eiichi Fujita Breakdown of academic impact, for papers by Shin Nishio Breakdown of academic impact, for papers by Hiroyuki Okamoto Breakdown of academic impact, for papers by J. A. King Breakdown of academic impact, for papers by Isao Matsui
Rankless by CCL
2026